Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSPREY: Methotrexate 100 mg standard-dose for unruptured tubal ectopic pregnancy
2020-004592-40Phase 4Unknown
- Sponsor
- University of Edinburgh
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in Ectopic pregnancy (EP), sponsored by University of Edinburgh. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on 2020-004592-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004592-40.